Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy

Bunk, Paul, Ergin, Ilgin, Maher, Timothy, Shah, Vyom, Bonney, Julia R, Kumar, Lokesh BSS, Chung, Charlie, Wellhausen, Nils, Moresco, Philip, Shao, Sarah, Habel, Jill, Mandati, Vinay, Rubino, Rachel, Rivadeneira, David E, Wilkinson, John E, Herrero, Laura, Westcott, Peter MK, Weinberg, Samuel E, Gill, Saar I, Agar, Nathalie YR, Beyaz, Semir (October 2026) Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy. Nature Immunology. ISSN 1529-2908

[thumbnail of 10.1038.s41590-026-02685-2.pdf] PDF
10.1038.s41590-026-02685-2.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.
Download (11MB)

Abstract

Most patients with solid tumors fail to sustain antitumor immunity, in part because immune cells cannot outcompete cancer cells inside the immunosuppressive tumor microenvironment. Here, we show the lipid-sensing transcription factor PPARδ is a compartment-specific determinant of cancer-immune fitness balance and immunotherapy efficacy. Activating PPARδ in cancer cells promotes their growth and impairs antitumor immunity, whereas activating it in immune cells drives tumor suppression and overrides tumor-promoting effects of cancer-intrinsic activation. Mechanistically, PPARδ enhances CD8+ T cell fitness against cancer through effector-associated chromatin remodeling and Cpt1a-mediated fatty acid oxidation. Therapeutically, PPARδ-activated CD8+ T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function. These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors.

Item Type: Paper
Subjects: diseases & disorders > cancer
diseases & disorders
diseases & disorders > cancer > drugs and therapies
diseases & disorders > cancer > drugs and therapies > Immunotherapy
CSHL Authors:
Communities: CSHL labs > Beyaz lab
CSHL labs > Fearon lab
CSHL labs > Meyer Lab
CSHL Cancer Center Shared Resources
CSHL Post Doctoral Fellows
School of Biological Sciences > Publications
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: 14 October 2026
Date Deposited: 15 Oct 2026 15:23
Last Modified: 15 Oct 2026 15:23
Related URLs:
URI: https://repository.cshl.edu/id/eprint/42341

Actions (login required)

Administrator's edit/view item Administrator's edit/view item